Home / Companies / Par Pharmaceutical Companies Inc / Trends
Par Pharmaceutical Companies Inc H-1B trends
Quarterly LCA aggregate trend points for Par Pharmaceutical Companies Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Par Pharmaceutical Companies Inc span 2016 Q2 to 2021 Q3, peaking at 11 filings in 2017 Q2.
The most recent reported period (2021 Q3) shows 2 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2016 Q2 | 6 | 5 | 5 | $102,584 | $84,018 | 6 | 100.0% |
| 2017 Q2 | 11 | 9 | 5 | $94,373 | $81,678 | 11 | 100.0% |
| 2018 Q2 | 7 | 5 | 4 | $140,575 | $109,102 | 7 | 100.0% |
| 2019 Q2 | 2 | 2 | 2 | $153,946 | $122,065 | 2 | 100.0% |
| 2020 Q1 | 1 | 1 | 1 | $131,733 | $79,830 | 1 | 100.0% |
| 2020 Q2 | 2 | 2 | 2 | $125,000 | $104,822 | 2 | 100.0% |
| 2021 Q1 | 1 | 1 | 1 | $263,938 | $148,075 | 1 | 100.0% |
| 2021 Q2 | 2 | 2 | 2 | $193,080 | $135,148 | 2 | 100.0% |
| 2021 Q3 | 2 | 2 | 2 | $193,080 | $135,148 | 2 | 100.0% |
Frequently asked questions
- How have H-1B filings for Par Pharmaceutical Companies Inc changed over time?
- H-1B LCA filings for Par Pharmaceutical Companies Inc span 2016 Q2 to 2021 Q3, peaking at 11 filings in 2017 Q2. The most recent reported period (2021 Q3) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=par+pharmaceutical+companies+inc&metric=lca_countJSON